These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 11267012)

  • 1. Primate skin allotransplantation with anti-CD154 monotherapy.
    Elster EA; Xu H; Tadaki DK; Burkly LC; Berning JD; Baumgartner RE; Cruzata F; Patterson NB; Harlan DM; Kirk AD
    Transplant Proc; 2001; 33(1-2):675-6. PubMed ID: 11267012
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment with the humanized CD154-specific monoclonal antibody, hu5C8, prevents acute rejection of primary skin allografts in nonhuman primates.
    Elster EA; Xu H; Tadaki DK; Montgomery S; Burkly LC; Berning JD; Baumgartner RE; Cruzata F; Marx R; Harlan DM; Kirk AD
    Transplantation; 2001 Nov; 72(9):1473-8. PubMed ID: 11707732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of ABI793, a novel human anti-human CD154 monoclonal antibody, in cynomolgus monkey renal allotransplantation.
    Schuler W; Bigaud M; Brinkmann V; Di Padova F; Geisse S; Gram H; Hungerford V; Kleuser B; Kristofic C; Menninger K; Tees R; Wieczorek G; Wilt C; Wioland C; Zurini M
    Transplantation; 2004 Mar; 77(5):717-26. PubMed ID: 15021835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful conversion from conventional immunosuppression to anti-CD154 monoclonal antibody costimulatory molecule blockade in rhesus renal allograft recipients.
    Cho CS; Burkly LC; Fechner JH; Kirk AD; Oberley TD; Dong Y; Brunner KG; Peters D; Tenhoor CN; Nadeau K; Yagci G; Ishido N; Schultz JM; Tsuchida M; Hamawy MM; Knechtle SJ
    Transplantation; 2001 Aug; 72(4):587-97. PubMed ID: 11544416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of dose and duration of anti-CD154 antibody therapy in preventing renal allograft rejection in a nonhuman primate model.
    Xu H; Elster E; Batty D; Berning J; Burkly L; Kampen R; Swanson S; Tadaki D; Harlan D; Kirk A
    Transplant Proc; 2001; 33(1-2):223-4. PubMed ID: 11266788
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies investigating pretransplant donor-specific blood transfusion, rapamycin, and the CD154-specific antibody IDEC-131 in a nonhuman primate model of skin allotransplantation.
    Xu H; Montgomery SP; Preston EH; Tadaki DK; Hale DA; Harlan DM; Kirk AD
    J Immunol; 2003 Mar; 170(5):2776-82. PubMed ID: 12594309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutting edge: CD4+CD25+ alloantigen-specific immunoregulatory cells that can prevent CD8+ T cell-mediated graft rejection: implications for anti-CD154 immunotherapy.
    van Maurik Av; Herber M; Wood KJ; Jones ND
    J Immunol; 2002 Nov; 169(10):5401-4. PubMed ID: 12421913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD40-ligand in primate cardiac allograft and viral immunity.
    Pierson RN; Crowe JE; Pfeiffer S; Atkinson J; Azimzadeh A; Miller GG
    Immunol Res; 2001; 23(2-3):253-62. PubMed ID: 11444390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination induction therapy with monoclonal antibodies specific for CD80, CD86, and CD154 in nonhuman primate renal transplantation.
    Montgomery SP; Xu H; Tadaki DK; Celniker A; Burkly LC; Berning JD; Cruzata F; Elster EA; Gray G; Kampen RL; Swanson SJ; Harlan DM; Kirk AD
    Transplantation; 2002 Nov; 74(10):1365-9. PubMed ID: 12451232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virus-induced abrogation of transplantation tolerance induced by donor-specific transfusion and anti-CD154 antibody.
    Welsh RM; Markees TG; Woda BA; Daniels KA; Brehm MA; Mordes JP; Greiner DL; Rossini AA
    J Virol; 2000 Mar; 74(5):2210-8. PubMed ID: 10666251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two-signal blockade with anti-CD45RB and anti-CD154 monoclonal antibodies inhibits graft rejection via CD4-dependent mechanisms in allogeneic skin transplantation.
    Kim EY; Lee EN; Lee J; Park HJ; Chang CY; Jung DY; Choi SY; Lee SK; Joh JW; Kim SJ
    Exp Mol Med; 2006 Jun; 38(3):284-94. PubMed ID: 16819287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allograft rejection by primed/memory CD8+ T cells is CD154 blockade resistant: therapeutic implications for sensitized transplant recipients.
    Zhai Y; Meng L; Gao F; Busuttil RW; Kupiec-Weglinski JW
    J Immunol; 2002 Oct; 169(8):4667-73. PubMed ID: 12370407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical role of OX40 in CD28 and CD154-independent rejection.
    Demirci G; Amanullah F; Kewalaramani R; Yagita H; Strom TB; Sayegh MH; Li XC
    J Immunol; 2004 Feb; 172(3):1691-8. PubMed ID: 14734751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blocking of costimulatory pathways using monoclonal antibodies as a new strategy to prevent transplant rejection in a non-human primate model.
    Ossevoort MA; de Boer M; Lorré K; Van de Voorde A; Jonker M
    Transplant Proc; 1998 Jun; 30(4):1061-2. PubMed ID: 9636429
    [No Abstract]   [Full Text] [Related]  

  • 15. Mycophenolate mofetil is compatible with CD28/CD154 costimulatory blockade in preventing transplant rejection.
    Vu MD; Li Y; Strom TB; Li XC
    Transplantation; 2005 Mar; 79(6):736. PubMed ID: 15785384
    [No Abstract]   [Full Text] [Related]  

  • 16. CD154 on the surface of CD4+CD25+ regulatory T cells contributes to skin transplant tolerance.
    Jarvinen LZ; Blazar BR; Adeyi OA; Strom TB; Noelle RJ
    Transplantation; 2003 Nov; 76(9):1375-9. PubMed ID: 14627918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential of costimulation-based therapies for composite tissue allotransplantation.
    Elster EA; Blair PJ; Kirk AD
    Microsurgery; 2000; 20(8):430-4. PubMed ID: 11150995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel CD154 monoclonal antibody in acute and chronic rat vascularized cardiac allograft rejection.
    Yuan X; Dong VM; Coito AJ; Waaga AM; Salama AD; Benjamin CD; Sayegh MH; Chandraker A
    Transplantation; 2002 Jun; 73(11):1736-42. PubMed ID: 12084995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monotherapy with the novel human anti-CD154 monoclonal antibody ABI793 in rhesus monkey renal transplantation model.
    Kanmaz T; Fechner JJ; Torrealba J; Kim HT; Dong Y; Oberley TD; Schultz JM; Bloom DD; Katayama M; Dar W; Markovits J; Schuler W; Hu H; Hamawy MM; Knechtle SJ
    Transplantation; 2004 Mar; 77(6):914-20. PubMed ID: 15077037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of interferon alpha in allograft rejection.
    Benizri EJ; Gugenheim J; Bernard G; Tovey MG
    Transplant Proc; 1995 Feb; 27(1):413. PubMed ID: 7879043
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.